Factors associated with the use of botulinum toxin injections for adult strabismus in the IRIS Registry
Copyright © 2024 American Association for Pediatric Ophthalmology and Strabismus. Published by Elsevier Inc. All rights reserved..
This cross-sectional study used data from a large nationwide registry to describe the factors associated with use of botulinum toxin injections for adults with strabismus in the United States. Botulinum toxin injections were performed on 3.1% of adults undergoing an intervention for strabismus between 2013 and 2020. Adults treated with botulinum toxin injections were more likely to be older and female. Compared to non-Hispanic White patients, non-Hispanic Black patients were three times less likely to receive treatment with botulinum toxin after adjusting for age, sex, geographic region, and type of insurance. Efforts to understand the factors contributing to disparities in the use of botulinum toxin for strabismus may lead to opportunities for more equitable access to this intervention.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:28 |
|---|---|
| Enthalten in: |
Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus - 28(2024), 1 vom: 22. Feb., Seite 103817 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Oke, Isdin [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 18.03.2024 Date Revised 23.04.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.jaapos.2023.09.011 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM367354071 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM367354071 | ||
| 003 | DE-627 | ||
| 005 | 20240423232112.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240121s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jaapos.2023.09.011 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1384.xml |
| 035 | |a (DE-627)NLM367354071 | ||
| 035 | |a (NLM)38244912 | ||
| 035 | |a (PII)S1091-8531(24)00017-X | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Oke, Isdin |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Factors associated with the use of botulinum toxin injections for adult strabismus in the IRIS Registry |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 18.03.2024 | ||
| 500 | |a Date Revised 23.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2024 American Association for Pediatric Ophthalmology and Strabismus. Published by Elsevier Inc. All rights reserved. | ||
| 520 | |a This cross-sectional study used data from a large nationwide registry to describe the factors associated with use of botulinum toxin injections for adults with strabismus in the United States. Botulinum toxin injections were performed on 3.1% of adults undergoing an intervention for strabismus between 2013 and 2020. Adults treated with botulinum toxin injections were more likely to be older and female. Compared to non-Hispanic White patients, non-Hispanic Black patients were three times less likely to receive treatment with botulinum toxin after adjusting for age, sex, geographic region, and type of insurance. Efforts to understand the factors contributing to disparities in the use of botulinum toxin for strabismus may lead to opportunities for more equitable access to this intervention | ||
| 650 | 4 | |a Case Reports | |
| 650 | 7 | |a Botulinum Toxins, Type A |2 NLM | |
| 650 | 7 | |a EC 3.4.24.69 |2 NLM | |
| 700 | 1 | |a Elze, Tobias |e verfasserin |4 aut | |
| 700 | 1 | |a Miller, Joan W |e verfasserin |4 aut | |
| 700 | 1 | |a Lorch, Alice C |e verfasserin |4 aut | |
| 700 | 1 | |a Hunter, David G |e verfasserin |4 aut | |
| 700 | 0 | |a IRIS Registry Analytic Center Consortium |e verfasserin |4 aut | |
| 700 | 1 | |a Pershing, Suzann |e investigator |4 oth | |
| 700 | 1 | |a Hyman, Leslie |e investigator |4 oth | |
| 700 | 1 | |a Haller, Julia A |e investigator |4 oth | |
| 700 | 1 | |a Lee, Aaron Y |e investigator |4 oth | |
| 700 | 1 | |a Lee, Cecilia S |e investigator |4 oth | |
| 700 | 1 | |a Lum, Flora |e investigator |4 oth | |
| 700 | 1 | |a Miller, Joan W |e investigator |4 oth | |
| 700 | 1 | |a Lorch, Alice C |e investigator |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus |d 1997 |g 28(2024), 1 vom: 22. Feb., Seite 103817 |w (DE-627)NLM096493356 |x 1528-3933 |7 nnns |
| 773 | 1 | 8 | |g volume:28 |g year:2024 |g number:1 |g day:22 |g month:02 |g pages:103817 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jaapos.2023.09.011 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 28 |j 2024 |e 1 |b 22 |c 02 |h 103817 | ||